fashion -WSS

fashion

author：fashion 2025-09-14 11:44:09 - browse：4

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

WSS

Setback for rare diseases as Taysha Gene Therapies pulls back

Some top drug companies are starting to take action on climate

5 important ways Henrietta Lacks changed medical science

Health insurers' Q3 question: how much care are people getting?

Adults seen as increasingly susceptible to measles

Mega Millions pot grows to $1.25 billion after no winner

leisure time

fashion

explore

Jerome Adams on the need for new antivirals for Covid

NIH launches clinical trials and new research office for long Covid

Sports medicine is finally prioritizing gender equality

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

What does generative AI mean for health care? We asked experts

New safety details link Apellis eye drug to rare cases of blindness

Medicare proposal to cover medical devices draws a mixed reaction

Experts study whether long Covid risk adds up with each reinfection

Hepatitis C has a cure — but many Americans still lack access to it

Congress extends some pandemic preparedness programs

focus

‘Oppenheimer’ and the risks of AI in health care

WHO recommends second malaria vaccine

Mitch McConnell episode has important public health takeaway

Some top drug companies are starting to take action on climate

Mega Millions pot grows to $1.25 billion after no winner

New oral drug delivery patch is modeled after octopus tentacles

focus

leisure time

entertainment

Wikipedia